Envestnet Asset Management’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.86M | Buy |
51,682
+1,422
| +3% | +$51.2K | ﹤0.01% | 2876 |
|
|
2025
Q1 | $1.98M | Buy |
50,260
+149
| +0.3% | +$5.88K | ﹤0.01% | 2735 |
|
|
2024
Q4 | $1.51M | Buy |
50,111
+5,135
| +11% | +$155K | ﹤0.01% | 2875 |
|
|
2024
Q3 | $1.05M | Buy |
44,976
+7,097
| +19% | +$166K | ﹤0.01% | 3110 |
|
|
2024
Q2 | $674K | Sell |
37,879
-1,002
| -3% | -$17.8K | ﹤0.01% | 3281 |
|
|
2024
Q1 | $591K | Sell |
38,881
-7,826
| -17% | -$119K | ﹤0.01% | 3333 |
|
|
2023
Q4 | $798K | Buy |
46,707
+5,359
| +13% | +$91.5K | ﹤0.01% | 3070 |
|
|
2023
Q3 | $346K | Buy |
41,348
+13,526
| +49% | +$113K | ﹤0.01% | 3451 |
|
|
2023
Q2 | $691K | Buy |
27,822
+11,973
| +76% | +$297K | ﹤0.01% | 3028 |
|
|
2023
Q1 | $238K | Buy |
15,849
+5,394
| +52% | +$81.1K | ﹤0.01% | 3570 |
|
|
2022
Q4 | $124K | Buy |
+10,455
| New | +$124K | ﹤0.01% | 3776 |
|
|
2021
Q4 | – | Sell |
-8,574
| Closed | -$285K | – | 3945 |
|
|
2021
Q3 | $285K | Sell |
8,574
-3,847
| -31% | -$128K | ﹤0.01% | 3322 |
|
|
2021
Q2 | $482K | Buy |
12,421
+1,513
| +14% | +$58.7K | ﹤0.01% | 3010 |
|
|
2021
Q1 | $526K | Buy |
10,908
+4,154
| +62% | +$200K | ﹤0.01% | 2818 |
|
|
2020
Q4 | $351K | Buy |
+6,754
| New | +$351K | ﹤0.01% | 2850 |
|